| name | es-cushing-suggest-repeat-transsphenoidal-surgery |
| description | Suggests repeat transsphenoidal surgery for patients with persistent hypercortisolism after initial transsphenoidal surgery when imaging shows evidence of incomplete resection or a pituitary lesion. Clinical triggers include postoperative MRI revealing residual adenoma, persistent elevated UFC or late-night salivary cortisol, and visible pituitary lesion on imaging. |
Suggest Repeat Transsphenoidal Surgery for Evidence of Incomplete Resection or Pituitary Lesion on Imaging
STEP 1 — Gather Information
Collect postoperative biochemical tests (UFC, late-night salivary cortisol, serum cortisol) and pituitary MRI performed 1–3 months after initial transsphenoidal surgery; document surgical report for extent of resection and any intraoperative findings.
STEP 2 — Rule In / Rule Out
Rule in persistent hypercortisolism if UFC or late-night salivary cortisol remains above the upper limit of normal on two occasions; rule out transient hypercortisolism due to stress or medication by confirming biochemical persistence and excluding exogenous glucocorticoid use.
STEP 3 — Classify or Stratify
Classify as candidate for repeat transsphenoidal surgery if MRI shows a residual pituitary lesion or evidence of incomplete resection (e.g., residual adenoma, enhancing lesion in sella) and the patient is a suitable surgical candidate; otherwise consider alternative second-line therapies.
STEP 4 — Decide
If criteria are met, refer to an experienced pituitary surgeon for evaluation and schedule repeat transsphenoidal surgery; if not, initiate medical therapy or consider radiotherapy based on patient preference and tumor characteristics.
Clinical Guardrails / Mimics / Pitfalls
Do not repeat surgery without clear biochemical evidence of persistent disease and imaging correlate; avoid surgery in patients with high surgical risk or uncontrolled comorbidities; be aware that postoperative MRI can show postoperative changes mimicking residual tumor, so correlate with clinical and biochemical data.
Concrete Clinical Example
A 42‑year‑old woman undergoes transsphenoidal surgery for Cushing’s disease; postoperative MRI at 8 weeks shows a 4 mm enhancing lesion in the sella and UFC remains 2× ULN; she is referred for repeat transsphenoidal surgery, which achieves biochemical remission.
Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2015-1818
